CVS Health Corporation Company Profile (NYSE:CVS)

About CVS Health Corporation

CVS Health Corporation logoCVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions. The Retail Pharmacy segment includes retail drugstores, online retail pharmacy Websites and its retail healthcare clinics.

Industry, Sector and Symbol:
  • Sector: Retail/Wholesale
  • Industry: Health Care Plans
  • Sub-Industry: Drug Retail
  • Exchange: NYSE
  • Symbol: CVS
  • CUSIP: 12665010
Key Metrics:
  • Previous Close: $79.69
  • 50 Day Moving Average: $79.81
  • 200 Day Moving Average: $85.14
  • 52-Week Range: $69.30 - $106.67
  • Trailing P/E Ratio: 16.23
  • Foreward P/E Ratio: 12.55
  • P/E Growth: 1.31
  • Market Cap: $84.55B
  • Outstanding Shares: 1,061,000,000
  • Beta: 0.85
  • Net Margins: 3.00%
  • Return on Equity: 17.55%
  • Return on Assets: 6.74%
  • Debt-to-Equity Ratio: 0.70%
  • Current Ratio: 1.18%
  • Quick Ratio: 0.62%
Additional Links:
Companies Related to CVS Health Corporation:

Analyst Ratings

Consensus Ratings for CVS Health Corporation (NYSE:CVS) (?)
Ratings Breakdown: 6 Hold Ratings, 11 Buy Ratings
Consensus Rating:Buy (Score: 2.65)
Consensus Price Target: $96.24 (20.76% upside)

Analysts' Ratings History for CVS Health Corporation (NYSE:CVS)
DateFirmActionRatingPrice TargetDetails
2/11/2017Leerink SwannSet Price TargetBuy$90.00View Rating Details
2/9/2017Evercore ISILower Price TargetBuy$91.50 -> $84.00View Rating Details
2/8/2017Deutsche Bank AGReiterated RatingHold$88.00View Rating Details
2/6/2017Atlantic SecuritiesDowngradeOverweight -> Neutral$84.00View Rating Details
2/6/2017GuggenheimReiterated RatingBuy$90.00View Rating Details
2/2/2017Robert W. BairdDowngradeOutperform -> Neutral$86.00 -> $77.00View Rating Details
12/19/2016Credit Suisse GroupReiterated RatingBuyView Rating Details
12/18/2016Oppenheimer Holdings, Inc.Set Price TargetBuy$88.00View Rating Details
12/12/2016Jefferies Group LLCInitiated CoverageBuy -> Hold$122.00 -> $82.00View Rating Details
11/10/2016ArgusReiterated RatingBuy$120.00 -> $85.00View Rating Details
11/9/2016Barclays PLCReiterated RatingBuy$85.00View Rating Details
11/9/2016MizuhoBoost Price TargetBuy$90.00 -> $111.00View Rating Details
9/12/2016Morgan StanleyReiterated RatingHold$104.00View Rating Details
8/8/2016Citigroup Inc.Lower Price TargetNeutral$115.00 -> $108.00View Rating Details
8/3/2016FBR & CoReiterated RatingOutperform$120.00View Rating Details
5/5/2016MacquarieReiterated RatingOutperform$115.00View Rating Details
5/4/2016Royal Bank Of CanadaReiterated RatingOutperform$110.00 -> $115.00View Rating Details
2/10/2016Goldman Sachs Group, Inc. (The)Boost Price TargetNeutral$106.00 -> $110.00View Rating Details
11/3/2015S&P Equity ResearchUpgradeStrong-Buy$121.00View Rating Details
11/2/2015Raymond James Financial, Inc.Boost Price TargetOutperform$105.00 -> $110.00View Rating Details
11/2/2015BMO Capital MarketsBoost Price TargetOutperform$103.00 -> $113.00View Rating Details
11/2/2015J P Morgan Chase & CoLower Price TargetOverweight$128.00 -> $123.00View Rating Details
10/21/2015Cowen and CompanyLower Price Target$118.00 -> $113.00View Rating Details
(Data available from 2/20/2015 forward)


Earnings History for CVS Health Corporation (NYSE:CVS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/9/2017Q416$1.67$1.71$46.56 billion$46.00 billionViewListenView Earnings Details
11/8/2016Q316$1.57$1.64$45.29 billion$44.60 billionViewListenView Earnings Details
8/2/2016Q216$1.30$1.32$44.28 billion$43.70 billionViewN/AView Earnings Details
5/3/2016Q116$1.16$1.18$43.01 billion$43.20 billionViewN/AView Earnings Details
2/9/2016Q415$1.53$1.53$41.12 billion$41.15 billionViewN/AView Earnings Details
10/30/2015Q315$1.29$1.28$37.81 billion$38.50 billionViewListenView Earnings Details
8/4/2015Q215$1.20$1.22$37.18 billion$37.20 billionViewN/AView Earnings Details
5/1/2015Q115$1.08$1.14$35.93 billion$36.30 billionViewN/AView Earnings Details
2/10/2015Q414$1.20$1.21$36.06 billion$37.06 billionViewN/AView Earnings Details
11/4/2014Q314$1.13$1.15$34.74 billion$35.00 billionViewN/AView Earnings Details
8/5/2014Q214$1.10$1.13$33.47 billion$34.60 billionViewN/AView Earnings Details
5/2/2014Q114$1.05$1.02$32.31 billion$32.70 billionViewN/AView Earnings Details
2/11/2014Q413$1.11$1.12$32.67 million$32.80 millionViewN/AView Earnings Details
11/5/2013Q313$1.02$1.05$31.53 billion$32.00 billionViewListenView Earnings Details
8/6/2013Q2 2013$0.96$0.97$31.13 billion$31.25 billionViewListenView Earnings Details
5/1/2013Q113$0.79$0.83$30.36 billion$30.76 billionViewListenView Earnings Details
2/6/2013Q4 2012$1.10$1.14$31.13 billion$31.40 billionViewListenView Earnings Details
11/6/2012Q312$0.84$0.85$30.09 billion$30.23 billionViewN/AView Earnings Details
8/7/2012$0.80$0.81ViewN/AView Earnings Details
5/2/2012$0.63$0.65ViewN/AView Earnings Details
11/3/2011$0.68$0.70ViewN/AView Earnings Details
8/4/2011$0.65$0.65ViewN/AView Earnings Details
5/5/2011$0.55$0.57ViewN/AView Earnings Details
2/3/2011$0.79$0.80ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for CVS Health Corporation (NYSE:CVS)
Current Year EPS Consensus Estimate: $5.85 EPS
Next Year EPS Consensus Estimate: $6.35 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$1.15$1.19$1.17
Q2 20166$1.30$1.36$1.31
Q3 20165$1.56$1.58$1.57
Q4 20165$1.65$1.79$1.69
Q1 20174$1.09$1.33$1.18
Q2 20174$1.29$1.35$1.33
Q3 20174$1.49$1.65$1.59
Q4 20174$1.70$1.92$1.77
Q1 20182$1.33$1.49$1.41
Q2 20182$1.42$1.62$1.52
Q3 20181$1.72$1.72$1.72
Q4 20181$1.91$1.91$1.91
(Data provided by Zacks Investment Research)


Current Dividend Information for CVS Health Corporation (NYSE:CVS)
Annual Dividend:$2.00
Dividend Yield:2.51%
Dividend Growth:23.60% (3 Year Average)
Payout Ratio:40.65% (Based on Trailing 12 Months of Earnings)
34.19% (Based on Current Year Consensus EPS Estimate)
31.50% (Based on Next Year Consensus EPS Estimate)
Track Record:9 Years of Consecutive Dividend Growth

Dividend History for CVS Health Corporation (NYSE:CVS)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for CVS Health Corporation (NYSE:CVS)
Insider Ownership Percentage: 0.58%
Institutional Ownership Percentage: 81.29%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/16/2017Jonathan C RobertsEVPSell61,196$80.00$4,895,680.00View SEC Filing  
5/5/2016Larry J MerloCEOSell38,247$105.00$4,015,935.00View SEC Filing  
5/5/2016Troyen A BrennanEVPSell7,517$105.00$789,285.00View SEC Filing  
4/1/2016Stephen J GoldEVPSell21,922$105.00$2,301,810.00View SEC Filing  
3/9/2016Larry J MerloCEOSell38,247$100.00$3,824,700.00View SEC Filing  
2/11/2016Jonathan C. RobertsEVPSell23,355$92.86$2,168,745.30View SEC Filing  
2/1/2016Larry J. MerloCEOSell46,393$96.14$4,460,223.02View SEC Filing  
1/11/2016Larry J. MerloCEOSell46,393$95.00$4,407,335.00View SEC Filing  
10/27/2015Troyen A. BrennanEVPSell23,603$105.00$2,478,315.00View SEC Filing  
7/20/2015Eva C BorattoSVPSell22,107$110.34$2,439,286.38View SEC Filing  
7/15/2015Lisa BisacciaEVPSell49,908$110.00$5,489,880.00View SEC Filing  
6/1/2015C David Brown IIDirectorSell10,000$102.57$1,025,700.00View SEC Filing  
5/1/2015C David Brown IIDirectorSell15,000$100.27$1,504,050.00View SEC Filing  
4/10/2015Andrew SussmanEVPSell17,638$102.38$1,805,778.44View SEC Filing  
4/2/2015Troyen A BrennanEVPSell33,384$102.48$3,421,192.32View SEC Filing  
3/23/2015Troyen A BrennanEVPSell33,274$104.94$3,491,773.56View SEC Filing  
3/20/2015C David Brown IIDirectorSell25,000$104.30$2,607,500.00View SEC Filing  
1/7/2015Jonathan C RobertsEVPSell86,487$95.31$8,243,075.97View SEC Filing  
1/5/2015Larry J MerloCEOSell144,144$94.30$13,592,779.20View SEC Filing  
1/2/2015Andrew SussmanSVPSell4,220$95.67$403,727.40View SEC Filing  
1/2/2015Per Gh LofbergEVPSell347,343$95.28$33,094,841.04View SEC Filing  
11/7/2014Helena FoulkesEVPSell46,325$88.06$4,079,379.50View SEC Filing  
10/27/2014Lisa BisacciaSVPSell33,507$85.00$2,848,095.00View SEC Filing  
9/2/2014Andrew SussmanSVPSell9,020$79.45$716,639.00View SEC Filing  
8/6/2014J. David JoynerEVPSell123,516$76.10$9,399,567.60View SEC Filing  
7/21/2014Eva C BorattoSVPSell22,107$76.77$1,697,154.39View SEC Filing  
7/1/2014David M DentonCFOSell74,989$75.88$5,690,165.32View SEC Filing  
4/2/2014Eva BorattoSVPSell17,108$74.51$1,274,717.08View SEC Filing  
3/31/2014Troyen BrennanEVPSell18,867$74.33$1,402,384.11View SEC Filing  
1/3/2014David DentonCFOSell14,113$70.50$994,966.50View SEC Filing  
1/3/2014Per Gh LofbergEVPSell790,888$70.54$55,789,239.52View SEC Filing  
1/2/2014Jonathan RobertsEVPSell162,192$70.61$11,452,377.12View SEC Filing  
1/2/2014Larry MerloCEOSell228,875$70.76$16,195,195.00View SEC Filing  
12/10/2013Lisa BisacciaSVPSell12,057$68.00$819,876.00View SEC Filing  
11/18/2013Troyen BrennanEVPSell35,387$65.61$2,321,741.07View SEC Filing  
10/18/2013Eva C BorattoSVPSell11,053$60.50$668,706.50View SEC Filing  
10/11/2013Eva BorattoSVPSell11,053$59.50$657,653.50View SEC Filing  
9/13/2013Helena FoulkesEVPSell53,546$60.00$3,212,760.00View SEC Filing  
9/9/2013Helena FoulkesEVPSell47,568$58.65$2,789,863.20View SEC Filing  
9/4/2013Andrew SussmanSVPSell9,020$58.36$526,407.20View SEC Filing  
10/4/2012Andrew SussmanSVPSell9,020$49.00$441,980.00View SEC Filing  
10/1/2012Thomas M MoriartyEVPBuy6,164$48.67$300,001.88View SEC Filing  
9/13/2012David M DentonCFOSell11,526$47.00$541,722.00View SEC Filing  
8/21/2012Jean Pierre MillonDirectorSell33,726$45.73$1,542,289.98View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for CVS Health Corporation (NYSE:CVS)
News IconArgus On CVS Health Corp (CVS) (NYSE:CVS) - February 19 at 11:11 AM
News IconRGT Capital Management Ltd. Takes Position in CVS Health Corporation (CVS) (NYSE:CVS) - February 18 at 4:23 PM
News IconCVS Health Corporation (NYSE:CVS) Analyst Estimates And Rating (NYSE:CVS) - February 18 at 4:23 PM
News IconTaking a Look at the Data Behind CVS Health Corporation (CVS) (NYSE:CVS) - February 18 at 9:34 AM
News IconCVS Health Corporation (CVS) EVP Sells 61196 Shares of Stock (NYSE:CVS) - February 18 at 9:34 AM
News IconRevenue Approximations Analysis: Anadarko Petroleum Corporation (APC), CVS Health Corporation (CVS) - StockNewsJournal (NYSE:CVS) - February 17 at 3:38 PM logoIt Has Worked: CVS Health Corp (NYSE:CVS) Says Of Its Exit Of Cigarette Business - Market Exclusive (NYSE:CVS) - February 17 at 3:38 PM logoIt Has Worked: CVS Health Corp (CVS) Says Of Its Exit Of Cigarette Business (NYSE:CVS) - February 17 at 3:38 PM
News IconCVS Health Corporation (CVS): What's the Story? - StockNewsJournal (NYSE:CVS) - February 17 at 8:15 AM
News IconHarvest Capital Management Inc Sells 500 Shares of CVS Health Corporation (CVS) (NYSE:CVS) - February 16 at 11:39 PM
News IconAshburton Jersey Ltd Has $12619000 Position in CVS Health Corporation (CVS) (NYSE:CVS) - February 16 at 11:39 PM
News IconStock On the Run: CVS Health Corporation (NYSE:CVS) (NYSE:CVS) - February 16 at 11:39 PM
News IconCVS Health named one of the ‘World’s Most Admired’ companies (NYSE:CVS) - February 16 at 6:39 PM logoCVS HEALTH CORP Financials (NYSE:CVS) - February 16 at 6:39 PM logoCVS Health Research Institute Study Confirms that the Company's Tobacco Removal Decision Reduced Cigarette Purchases Nationwide (NYSE:CVS) - February 16 at 6:38 PM logoCVS Health And Breathe California Announce Statewide Finalists In Student Film Contest On Youth Smoking (NYSE:CVS) - February 16 at 6:38 PM
News IconTaking a Look at the Chart for CVS Health Corporation (CVS) - The USA Commerce (NYSE:CVS) - February 16 at 1:37 PM logoFORTUNE® Recognizes CVS Health on List of "World's Most Admired Companies" (NYSE:CVS) - February 16 at 1:37 PM logo2 Stocks To Buy And Hold For The Next 2 Years (NYSE:CVS) - February 16 at 1:37 PM
News IconCVS Health Corporation (CVS) Stake Cut by Horizon Investment Services LLC (NYSE:CVS) - February 14 at 9:01 PM logoBetter Buy: CVS Health Corporation vs. Express Scripts (NYSE:CVS) - February 14 at 4:42 PM logo'Made in the USA' lawsuit against CVS Health is dismissed - Reuters (NYSE:CVS) - February 14 at 3:59 PM logoBetter Buy: CVS Health Corporation vs. Express Scripts - Motley Fool (NYSE:CVS) - February 14 at 3:59 PM logo"Made in the USA" lawsuit against CVS Health is dismissed (NYSE:CVS) - February 14 at 3:59 PM logoETFs with exposure to CVS Health Corp. : February 14, 2017 (NYSE:CVS) - February 14 at 3:59 PM
News IconAnalysts Recommendation and Price Reaction History on: CVS Health Corp (NYSE:CVS) (NYSE:CVS) - February 14 at 3:26 AM
News IconStock Price of CVS Health Corporation (CVS) Increases 4.07% (NYSE:CVS) - February 14 at 3:26 AM logoMinuteClinic to Offer Free "Know Your Numbers" Screenings on Valentine's Day at Locations Nationwide (NYSE:CVS) - February 13 at 5:19 PM logoCVS Health Earns CEO Cancer Gold Standard Accreditation (NYSE:CVS) - February 13 at 5:19 PM logoCVS Health Corp. :CVS-US: Earnings Analysis: 2016 By the Numbers : February 13, 2017 (NYSE:CVS) - February 13 at 5:19 PM
News IconCVS Health Corporation (NYSE:CVS) Equity Price Target Fixed At $91.354 - Transcript Daily (NYSE:CVS) - February 12 at 9:46 PM
News IconThe Stock In Focus – CVS Health Corporation (NYSE:CVS) - Transcript Daily (NYSE:CVS) - February 10 at 10:06 PM logoVeritas Asset Management LLP Buys CVS Health, Baidu, Welltower, Sells Varian Medical Systems, Alibaba Group ... - (NYSE:CVS) - February 10 at 10:06 PM logoCVS Health: Hidden Value? - Seeking Alpha (NYSE:CVS) - February 10 at 10:06 PM logoCVS Health (CVS) Q4 2016 Results - Earnings Call Transcript (NYSE:CVS) - February 10 at 4:59 PM
News IconResearch Report for: CVS Health Corporation (NYSE:CVS) (NYSE:CVS) - February 10 at 4:59 PM
News IconCVS Health Corporation (NYSE:CVS) Missed Earnings 2 times (NYSE:CVS) - February 10 at 4:59 PM
News IconWhich analysts are covering CVS Health Corporation (CVS)? (NYSE:CVS) - February 10 at 4:59 PM
News IconCVS Health Corporation (CVS) Updates Q1 Earnings Guidance (NYSE:CVS) - February 10 at 4:59 PM
News IconAt Bancorp Cuts Position in CVS Health Corp (CVS) by $4348549 (NYSE:CVS) - February 10 at 4:59 PM logoPBMs are able to negotiate on drug prices: Dave Dorman (NYSE:CVS) - February 10 at 4:59 PM logoCVS Health Corp. :CVS-US: Earnings Analysis: Q4, 2016 By the Numbers : February 10, 2017 (NYSE:CVS) - February 10 at 4:59 PM logo5 Things CVS Health Management Said That You'll Want to Know (NYSE:CVS) - February 10 at 4:59 PM
News IconCVS Health beats 4Q profit forecasts - Fox Business (NYSE:CVS) - February 10 at 3:12 AM
News IconCVS Health beats 4Q profit forecasts (NYSE:CVS) - February 9 at 10:09 PM
News IconWhy CVS Health Corp (NYSE: CVS) stock is falling (NYSE:CVS) - February 9 at 10:09 PM logoCVS HEALTH CORPORATION (NYSE:CVS) Files An 8-K Results of Operations and Financial Condition (NYSE:CVS) - February 9 at 10:09 PM
News IconCVS Health Corp (NYSE:CVS)’s Pharmacy Services Results Are Better Than Expected (NYSE:CVS) - February 9 at 10:09 PM logoEdited Transcript of CVS earnings conference call or presentation 9-Feb-17 1:30pm GMT (NYSE:CVS) - February 9 at 10:09 PM
News IconDrilling Down Into the Charts for CVS Health Corporation (CVS) - The USA Commerce (NYSE:CVS) - February 9 at 5:07 PM


What is CVS Health Corporation's stock symbol?

CVS Health Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

How often does CVS Health Corporation pay dividends? What is the dividend yield for CVS Health Corporation?

CVS Health Corporation announced a quarterly dividend on Thursday, December 22nd. Investors of record on Tuesday, January 24th will be given a dividend of $0.50 per share on Thursday, February 2nd. This represents a $2.00 dividend on an annualized basis and a yield of 2.51%. The ex-dividend date of this dividend is Friday, January 20th. This is a positive change from CVS Health Corporation's previous quarterly dividend of $0.43.

Where is CVS Health Corporation's stock going? Where will CVS Health Corporation's stock price be in 2017?

17 equities research analysts have issued 12 month target prices for CVS Health Corporation's shares. Their predictions range from $77.00 to $120.00. On average, they expect CVS Health Corporation's share price to reach $96.24 in the next year.

When will CVS Health Corporation announce their earnings?

CVS Health Corporation is scheduled to release their next quarterly earnings announcement on Monday, May, 1st 2017.

What are analysts saying about CVS Health Corporation stock?

Here are some recent quotes from research analysts about CVS Health Corporation stock:

  • Evercore ISI analysts commented, "While the quarter proved generally uneventful and guidance was reiterated on the surface (albeit some moving parts below ' dollar profit targets were unchanged in our view ' much of the delta related to where 4Q came out vs mid-point and lower inflation outlook), investors have reacted negatively to the lack of clarity on several key issues with respect to business model risk that in our minds is unlikely to dissipate until later in the year. We think management did an admirable job on the DIR fee issue and a reasonable job on gross to net / rebates, but the reality is that policy noise is unlikely to dissipate and the outlook for 2018 won't start to gain clarity until the summer. We think once we get initial color on the PBM selling season, a better understanding of underlying pharmacy share shifts and profit headwinds and ultimately gain a better picture of 2018 the multiple may start to see some relief. Until then CVS shares remain inexpensive and highly leveraged to tax reform and it appears as if many years of execution are being overshadowed by a tough 18 month stretch. Given how far shares have fallen and in our view strong FCF yield support we retain our Buy rating but acknowledge the path to returns from here is likely most appropriate for those with a multi-year time horizon and a 'deep value' focus." (2/9/2017)
  • According to Zacks Investment Research, "CVS Health posted better-than-expected second-quarter with respected to adjusted EPS. However, revenues missed the Zacks Consensus Estimate. The company’s Pharmacy Services segment continues to benefit from growth in the Specialty Pharmacy business while the Retail Pharmacy segment is gaining from increased same-store sales. We take note of the recently completed Omnicare and Target Pharmacy buyouts which, according to CVS, are strategically perfect fits. CVS Health expects to benefit with multiple opportunities for driving enterprise value from Omnicare and Target in both the near and long term. CVS Health also expects to see market share gain in its specialty pharmacy suite of services with differentiated specialty offerings providing a high level of clinical support to patients. However, the competitive landscape remains tough. The tussle for market share gain in the PBM and retail space also warrants caution." (8/3/2016)

  • Morgan Stanley analysts commented, "We are hosting a cc with CVS Health’s CFO, Dave Denton today 4/7 at 1:00pm ET to discuss strategy, the selling season, recent acquisitions, and future capital deployment opportunities." (4/7/2016)

Who owns CVS Health Corporation stock?

CVS Health Corporation's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include State Street Corp (4.15%), FMR LLC (2.57%), Barrow Hanley Mewhinney & Strauss LLC (1.71%), Franklin Resources Inc. (1.34%), Dimensional Fund Advisors LP (0.92%) and Vulcan Value Partners LLC (0.50%). Company insiders that own CVS Health Corporation stock include Andrew Sussman, C David Brown II, Eva C Boratto, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia, Stephen J Gold and Troyen A Brennan.

Who sold CVS Health Corporation stock? Who is selling CVS Health Corporation stock?

CVS Health Corporation's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Institutional Capital LLC, Aberdeen Asset Management PLC UK, Janus Capital Management LLC, Fred Alger Management Inc., FIL Ltd, Federated Investors Inc. PA and Westwood Holdings Group Inc.. Company insiders that have sold CVS Health Corporation stock in the last year include Jonathan C Roberts, Larry J Merlo, Stephen J Gold and Troyen A Brennan.

Who bought CVS Health Corporation stock? Who is buying CVS Health Corporation stock?

CVS Health Corporation's stock was purchased by a variety of institutional investors in the last quarter, including Barrow Hanley Mewhinney & Strauss LLC, Vulcan Value Partners LLC, Franklin Resources Inc., Arrowstreet Capital Limited Partnership, Thornburg Investment Management Inc., Asset Management One Co. Ltd., Russell Investments Group Ltd. and International Value Advisers LLC.

How do I buy CVS Health Corporation stock?

Shares of CVS Health Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of CVS Health Corporation stock cost?

One share of CVS Health Corporation stock can currently be purchased for approximately $79.69.

CVS Health Corporation (NYSE:CVS) Chart for Monday, February, 20, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Earnings History Chart

Earnings by Quarter for CVS Health Corporation (NYSE:CVS)

Dividend History Chart

Dividend Payments by Quarter for CVS Health Corporation (NYSE:CVS)

Last Updated on 2/20/2017 by Staff